Transparency – Support for Patients’ Organisations & their activities
Patients’ organisations play a key role in supporting work to improve diagnosis, treatment and care for many therapeutic areas where pharmaceutical companies may be active. This is particularly important in the field of rare diseases, where expertise is rare and where patients may often be the experts in their own or their family’s disease or condition.
In most cases, patient representative organisations rely on support from external sources, including from pharmaceutical and biotech companies.
Mereo respects the legitimate role played by patient organisations in improving health outcomes for people with rare diseases and is actively engaged in supporting efforts by this expert community.
As part of our commitment to create sustainable value to patients, shareholders and to the community, Mereo also supports transparency initiatives, including transparency in our interactions with and support for Patient Groups and their activities.
In order to secure future collaboration and to increase public awareness, we are committed to making our support – both financial and in-kind – to patients’ organisations, and to their related scientific meetings, publicly available on a half-yearly basis.
Never miss an update from Mereo. Sign up for and select the type of alerts you would like to receive by email.Register for Email Alerts
Share Price Information
Mereo is a specialty biopharma company developing innovative medicines for patients. Find out about our share price and latest trades.View Share Price